Community/Retail

This November, the National Association of Boards of Pharmacy is releasing a longer North American Pharmacist Licensure Examination.

I ran into an old friend at a party the other day. I'd known him since he was about 6 and he's now in his mid-20s. For some reason, the kid had taken a shine to me.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Novo Nordisk has submitted a supplemental application to the FDA to include data from the 2 phase 3b SWITCH trials in the prescribing information for insulin degludec (Tresiba), a once-daily basal insulin that provides a duration of action beyond 42 hours for patients with type 1 and type 2 diabetes.